Andelyn Biosciences to develop GM2 gangliosidosis therapy
The partnership aims to progress this gene therapy using Andelyn’s AAV Curator Platform.
Drug Development
BeOne Medicines and partners renew Brukinsa access programme for CLL
Faeth’s PIKTOR plus paclitaxel combo gains FDA fast track status
Fulcrum and Slate Medicines sign merger agreement
EMA validates Pfizer and Valneva’s Lyme disease vaccine
FDA grants fast track status to Phanes’ spevatamig for advanced BTC
BMS secures FDA accelerated approval for Zenbexus in multiple myeloma
Xanadu and University of Alberta to develop quantum algorithms for cancer
